Learn About Pseudomonas Stutzeri Infections

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Pseudomonas Stutzeri Infections Local Doctors?
AB
Alessandra Bragonzi
Elite
Highly rated in
3
conditions

Division Of Immunology

Infections And Cystic Fibrosis Unit, Transplantation And Infectious Diseases, Irccs San Raffaele Scientific Institute, 
Milan, IT 

Alessandra Bragonzi practices in Milan, Italy. Bragonzi is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. She is also highly rated in 3 other conditions, according to our data. Her top areas of expertise are Pseudomonas Stutzeri Infections, Cystic Fibrosis, Pneumonia, and Rhabditida Infections.

JK
James A. Karlowsky
James A. Karlowsky
Elite
Highly rated in
10
conditions

University Of Manitoba

Department Of Medical Microbiology And Infectious Diseases, Max Rady College Of Medicine, Rady Faculty Of Health Sciences, 
Winnipeg, MB, CA 

James Karlowsky practices in Winnipeg, Canada. Karlowsky is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Pseudomonas Stutzeri Infections, Methicillin-Resistant Staphylococcus Aureus (MRSA), Urinary Tract Infection (UTI), and Streptococcal Group A Infection.

 
 
 
 
Learn about our expert tiers
Learn more
GZ
George G. Zhanel
Elite
Highly rated in
12
conditions

University Of Manitoba

Winnipeg, MB, CA 

George Zhanel practices in Winnipeg, Canada. Zhanel is rated as an Elite expert by MediFind in the treatment of Pseudomonas Stutzeri Infections. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Pseudomonas Stutzeri Infections, Urinary Tract Infection (UTI), and Strep Throat.

View All Doctors
What are the Latest Advances for Pseudomonas Stutzeri Infections?
Case Report: Community-Acquired Burkholderia cepacia Pneumonia of a Patient with Pulmonary Tuberculosis.
Condition: Community-Acquired Burkholderia Cepacia Pneumonia
Journal: The American journal of tropical medicine and hygiene
Treatment Used: Meropenem and Antitubercular Therapy
Number of Patients: 1
Published: July 27, 2022
Stenotrophomonas maltophilia Infection Associated with COVID-19: A Case Series and Literature Review.
Condition: Stenotrophomonas Maltophilia Infection Associated with COVID-19
Journal: The American journal of case reports
Treatment Used: Trimethoprim-Sulfamethoxazole (TMP-SMX)
Number of Patients: 4
Published: July 19, 2022
Tired of the same old research?
Check Latest Advances
Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections.
Condition: Multi-Drug Resistant Pseudomonas Aeruginosa Infection
Journal: Medicina intensiva
Treatment Used: New Antibiotics
Number of Patients: 0
Published: July 15, 2022
View All Latest Advances
What are the latest Pseudomonas Stutzeri Infections Clinical Trials?
Molecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas Aeruginosa
Enrollment Status: Not yet recruiting
Publish Date: December 08, 2022
Intervention Type: Diagnostic Test

Summary: Pseudomonas aeruginosa (PA) is a ubiquitous aerobic, non-fermentative Gram-negative rod that is widely associated with nosocomial pneumonia and can lead to severe illness with poor outcomes, particularly in critically ill people due to the ability of some strains to cause lung epithelial injury and spread into the circulation. 2 In the intensive care unit, PA infection is ranked among the top five...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant Organisms
Enrollment Status: Not yet recruiting
Publish Date: November 30, 2022
Intervention Type: Drug
Study Phase: Phase 2

Summary: This is a randomized, open label, comparative Phase II trial being conducted to determine whether fecal microbiota transplant using Penn Microbiome Therapy (PMT) products helps standard therapy eradicate antibiotic-resistant bacteria.

View All Clinical Trials